title: Idelalisib-related pneumonitis.
authors.affiliation: AP-HP, Hôpital Saint-Louis, Service de Pneumologie, Paris, France.
authors.forename: Eglantine
authors.initials: E
authors.lastname: Haustraete
authors.affiliation: AP-HP, Hôpital Saint-Louis, Service de Pneumologie, Paris, France.
authors.forename: Julie
authors.initials: J
authors.lastname: Obert
authors.affiliation: Groupe Médical Mounier, Pneumologie, Grenoble, France.
authors.forename: Samia
authors.initials: S
authors.lastname: Diab
authors.affiliation: CHU Nantes, Service de Pneumologie, Nantes, France.
authors.forename: Sarah
authors.initials: S
authors.lastname: Abbes
authors.affiliation: AP-HP, Hôpital Saint-Louis, Service des Maladies du sang, Paris, France.
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Zini
authors.affiliation: AP-HP, Hôpital Saint-Louis, Service de Réanimation médicale, Paris, France.
authors.forename: Sandrine
authors.initials: S
authors.lastname: Valade
authors.affiliation: AP-HP, Hôpital Saint-Louis, Service de Maladies infectieuses, Paris, France.
authors.forename: Nathalie
authors.initials: N
authors.lastname: Lerolle
authors.affiliation: Institut Daniel Hollard, Service d'Hématologie-Cancérologie, Grenoble, France.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Albin
authors.affiliation: AP-HP, Hôpital Saint-Louis, Département d'Immuno-Hématologie, Paris, France.
authors.forename: Bertrand
authors.initials: B
authors.lastname: Arnulf
authors.affiliation: AP-HP, Hôpital Saint-Louis, Service de Dermatologie, Paris, France.
authors.forename: Jean-David
authors.initials: JD
authors.lastname: Bouaziz
authors.affiliation: AP-HP, Hôpital Saint-Louis, Service de Pneumologie, Paris, France.
authors.forename: Claire
authors.initials: C
authors.lastname: Hussenet
authors.affiliation: AP-HP, Hôpital Saint-Louis, Service de Pneumologie, Paris, France Univ Paris Diderot, Sorbonne Paris Cité, U1153 CRESS, Biostatistics and Clinical Epidemiology research team, Paris, France.
authors.forename: Abdellatif
authors.initials: A
authors.lastname: Tazi
authors.affiliation: AP-HP, Hôpital Saint-Louis, Service de Pneumologie, Paris, France Univ Paris Diderot, Sorbonne Paris Cité, U1153 CRESS, Biostatistics and Clinical Epidemiology research team, Paris, France anne.bergeron-lafaurie@aphp.fr.
authors.forename: Anne
authors.initials: A
authors.lastname: Bergeron
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications* / Q000188:drug therapy*; D008168:Lung / Q000000981:diagnostic imaging; D008297:Male; D011014:Pneumonia / Q000139:chemically induced*; D011687:Purines / Q000008:administration & dosage / Q000009:adverse effects*; D052999:Quinazolinones / Q000008:administration & dosage / Q000009:adverse effects*; D000069283:Rituximab / Q000008:administration & dosage; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D011687:Purines; D052999:Quinazolinones; D000069283:Rituximab; C552946:idelalisib